πŸ‡ΊπŸ‡Έ FDA
Patent

US 7723496

Preventives/remedies for cancer

granted A61KA61K38/1709A61K45/06

Quick answer

US patent 7723496 (Preventives/remedies for cancer) held by Takeda Pharmaceutical Company Limited expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/1709, A61K45/06, A61K48/00, A61P